Kyle Smith

Resolving medulloblastoma cellular architecture by single-cell genomics

Volker Hovestadt, Kyle Smith, Laure Bihannic et al. · Nature · 2019 · 430 citations · Full text

Life Sciences, Cancer Biology, Oncology +14

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)

Amar Gajjar, Giles Robinson, Kyle Smith et al. · Journal of Clinical Oncology · 2021 · 236 citations · Full text

Medicine, Oncology, Pediatrics +17

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial

Giles Robinson, Vasilisa A. Rudneva, Ivo Buchhalter et al. · The Lancet Oncology · 2018 · 231 citations · Full text

Medicine, Oncology, Pediatrics +17

Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

Jeff M. Michalski, Anna J. Janss, L. Gilbert Vezina et al. · Journal of Clinical Oncology · 2021 · 203 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Serial assessment of measurable residual disease in medulloblastoma liquid biopsies

Anthony P. Y. Liu, Kyle Smith, Rahul Kumar et al. · Cancer Cell · 2021 · 179 citations · Full text

Medicine, Oncology, Pathology +16